Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Emmaus Life Sciences, Inc. (EMMA)
USD0.01
+0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address
21250 Hawthorne Boulevard 90503
Torrance, CA, US
Torrance, CA, US
CEO
Willis C. Lee
Website
emmausmedical.com
IPO
2000-05-09
CIK 822370 ISIN US29137T1016
Also trades on
Other OTC · EMMA (USD)
Other OTC · EMMAW (USD)
Description
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical enterprise dedicated to the discovery, development, commercialization, and sale of treatments and therapies, primarily addressing rare and orphan diseases across the United States and internationally. The company's flagship product is Endari, an L-glutamine oral powder designed to mitigate the acute complications associated with sickle cell disease in patients aged five and above, covering both pediatric and adult populations. Furthermore, Emmaus maintains a collaborative arrangement with Kainos Medicine, Inc. for the preclinical advancement of Kainos' proprietary IRAK4 inhibitor, KM10544, which is being explored as a potential anti-cancer therapeutic. Established in 2000 as Emmaus Holdings, Inc., the organization rebranded to Emmaus Life Sciences, Inc. in September 2011 and operates from its headquarters in Torrance, California.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| MYnd | MYND | 2019-02-13 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.01
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
56.7K
Beta
8.86
Float Shares
42.77M
Free Float %
60.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +15.20% | +15.20% | +14.06% | -23.20% | +15.20% | -11.38% | -18.01% | -96.40% | -99.23% | -99.94% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.01
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-23.98
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-25.2% Q1'26: -17.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-20.0% Q1'26: -30.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-12.4% Q1'26: -17.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-2.8% Q1'26: -41.5% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +8.9% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+1.3% ★ Q1'26: +9.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-105.03× Q1'26: -9.89× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
128.5K
est: 323.0K (-60.2%)
|
1.32M
est: 1.44M (-8.8%)
|
22.75M
est: 2.28M (+896.6%)
|
23.17M
est: 5.08M (+356.0%)
|
20.61M
est: 23.00M (-10.4%)
|
18.39M
est: 19.00M (-3.2%)
|
29.60M
est: 20.00M (+48.0%)
|
16.65M
est: 21.00M (-20.7%)
|
12.45M
est: 30.15M (-58.7%)
|
| EBITDA |
-7.05M
est: -35.4K (-19,853.9%)
|
-10.13M
est: -158.0K (-6,311.1%)
|
-26.98M
est: -249.9K (-10,696.1%)
|
7.02M
est: -556.1K (+1,362.8%)
|
-12.76M
est: -2.52M (-406.9%)
|
-5.50M
est: -2.08M (-164.4%)
|
3.62M
est: -2.19M (+265.5%)
|
-910.0K
est: -3.68M (+75.2%)
|
-310.0K
est: -5.28M (+94.1%)
|
| EBIT |
-7.10M
est: -36.1K (-19,604.9%)
|
-10.25M
est: -161.1K (-6,261.0%)
|
-27.05M
est: -254.8K (-10,517.1%)
|
6.96M
est: -567.0K (+1,327.9%)
|
-12.82M
est: -2.57M (-399.4%)
|
-5.55M
est: -2.12M (-161.8%)
|
3.59M
est: -2.23M (+260.9%)
|
-932.0K
est: -3.72M (+75.0%)
|
-349.0K
est: -5.35M (+93.5%)
|
| Net Income |
-7.11M
est: -755.03M (+99.1%)
|
-9.60M
est: -709.50M (+98.6%)
|
-54.84M
est: -352.85M (+84.5%)
|
1.35M
est: -182.12M (+100.7%)
|
-15.95M
est: 1.90M (-940.6%)
|
-10.63M
est: -3.79M (-180.0%)
|
-3.73M
est: -4.43M (+15.7%)
|
-6.45M
est: 2.56M (-351.9%)
|
-7.49M
est: 3.84M (-295.0%)
|
| SGA |
5.82M
est: 300.9K (+1,833.2%)
|
9.36M
est: 1.34M (+595.9%)
|
23.99M
est: 2.13M (+1,027.8%)
|
18.54M
est: 4.73M (+291.8%)
|
19.32M
est: 21.43M (-9.9%)
|
20.66M
est: 17.70M (+16.7%)
|
23.53M
est: 18.63M (+26.3%)
|
16.69M
est: 19.93M (-16.3%)
|
11.05M
est: 28.61M (-61.4%)
|
| EPS |
-15.15
est: -11.94 (-26.9%)
|
-11.16
est: -11.22 (+0.5%)
|
-1.30
est: -5.58 (+76.7%)
|
0.03
est: -2.88 (+101.0%)
|
-0.32
est: 0.03 (-1,166.7%)
|
-0.21
est: -0.06 (-250.0%)
|
-0.07
est: -0.07 (-0.4%)
|
-0.10
est: 0.04 (-350.0%)
|
-0.12
est: 0.06 (-300.0%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.27M
OE per share TTM
-0.02
Owner's Yield
-157.13%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
14.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
31
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | fond s proměnným základním kapitálem, A.S. | 42.25M | 28.30% | 42.25M | — | 42.25M | — | CO | Czech Republic | 2016-09-15 | ↗ |
| 2 | JOHN PAPPAJOHN | 40.18M | 46.00% | — | — | — | — | IN | : | 2012-01-06 | ↗ |
| 3 | Yutaka Niihara, M.D., M.P.H. | 13.43M | 26.40% | 1.37M | 12.06M | 1.37M | 12.06M | IN | United States | 2022-11-09 | ↗ |
| 4 | Highland Capital Management, L.P. | 13.36M | 19.40% | — | 13.36M | — | — | IA, PN | Delaware | 2012-01-06 | ↗ |
| 5 | Highland Long/Short Healthcare Fund | 13.36M | 19.40% | 13.36M | — | 13.36M | — | IV, OO | Delaware | 2012-01-06 | ↗ |
| 6 | Strand Advisors, Inc. | 13.36M | 19.40% | — | 13.36M | — | — | HC, CO | Delaware | 2012-01-06 | ↗ |
| 7 | PAPPAJOHN | 13.02M | 21.50% | — | — | — | — | IN | : | 2010-07-28 | ↗ |
| 8 | Yutaka Niihara, M.D. M.P.H. | 12.78M | 25.60% | 12.68M | 103.3K | 12.68M | 10.00 | IN | United States | 2019-08-02 | ↗ |
| 9 | Soomi Niihara | 12.12M | 24.50% | 63.0K | 12.06M | 63.0K | 12.06M | IN | Citizenship or Place of Organization | 2022-11-09 | ↗ |
| 10 | Seah H. Lim, M.D., Ph.D. | 4.59M | 7.40% | 4.59M | — | 4.59M | — | IN | USA | 2023-12-22 | ↗ |
| 11 | Telcon RF Pharmaceuticals, Inc. | 4.15M | 8.70% | 4.15M | — | 4.15M | — | CO | South Korea | 2019-08-26 | ↗ |
| 12 | ANDY SASSINE | 3.60M | 6.04% | — | — | — | — | IN | USA | 2011-03-15 | ↗ |
| 13 | #39-1078128 | 2.34M | 9.10% | — | 2.34M | — | 2.34M | IA | WISCONSIN, U.S.A. | 2009-02-11 | ↗ |
| 14 | WILLIAM J. NASGOVITZ | 2.34M | 9.10% | — | 2.34M | — | 2.34M | IN | U.S.A. | 2009-02-11 | ↗ |
| 15 | George Lefevre | 2.25M | 9.20% | — | — | — | — | IN | United States of America | 2004-07-08 | ↗ |
| 16 | Scott W. Absher | 2.25M | 9.20% | — | — | — | — | IN | United States of America | 2004-07-08 | ↗ |
| 17 | Pacific Capital Management, LLC | 1.41M | 2.96% | 1.41M | — | 1.41M | — | OO | USA | 2019-08-23 | ↗ |
| 18 | Cummings Bay Capital Management GP, LLC | 1.17M | 6.20% | — | 1.17M | — | — | HC, OO | Delaware | 2013-02-14 | ↗ |
| 19 | Cummings Bay Capital Management, L.P. | 1.17M | 6.20% | — | 1.17M | — | — | IA, PN | Delaware | 2013-02-14 | ↗ |
| 20 | Highland Capital Management Services, Inc. | 1.17M | 6.20% | — | 1.17M | — | — | HC, CO | Delaware | 2013-02-14 | ↗ |
| 21 | James D. Dondero | 1.17M | 6.20% | — | 1.17M | — | — | IV, OO | Delaware | 2013-02-14 | ↗ |
| 22 | Pyxis Capital, L.P. | 987.1K | 5.30% | — | 987.1K | — | — | IA, PN | Delaware | 2013-02-14 | ↗ |
| 23 | Pyxis Long/Short Healthcare Fund | 987.1K | 5.30% | 987.1K | — | 987.1K | — | IV, OO | Delaware | 2013-02-14 | ↗ |
| 24 | Strand Advisors XVI, Inc. | 987.1K | 5.30% | — | 987.1K | — | — | HC, CO | Delaware | 2013-02-14 | ↗ |
| 25 | Jonathan M. Glaser | 763.3K | 6.23% | — | 763.3K | — | — | IN | USA | 2019-06-05 | ↗ |
| 26 | Nancy E. Glaser | 763.3K | 6.23% | — | 763.3K | — | — | IN | USA | 2019-06-05 | ↗ |
| 27 | The Jonathan & Nancy Glaser Family Trust DTD 12/16/1998 | 763.3K | 6.23% | 763.3K | — | 763.3K | — | OO | USA | 2019-06-05 | ↗ |
| 28 | ALLAN SCHWEITZER | 694.1K | 5.47% | — | 694.1K | — | 694.1K | HC, IN | California | 2019-06-07 | ↗ |
| 29 | JJBE 123, LLC | 694.1K | 5.47% | — | 694.1K | — | 694.1K | CO | California | 2019-06-07 | ↗ |
| 30 | Steven Emerson | 694.1K | 5.46% | 694.1K | — | 694.1K | — | IN | USA | 2019-06-05 | ↗ |
| 31 | AMENDMENT NO. 1 TO SCHEDULE 13D | 12.00 | 14.00% | 240.00 | — | 13.00 | 214.00 | IN | — | 2020-04-02 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
20.0K
Shares disposed
—
Cash buys
1.00
Cash sales
—
Net activity
+20,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | DU HENRY HUY | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-01 | Kuwahara Jon | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-16 | Lim Seah H. | Director | P-Purchase | A | Common stock, $0.001 par value | 20,000 | 0.04 | 800.00 | 4,606,626 | — | ↗ |
| 2024-02-29 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 77,000 | 0.13 | 10.0K | 159,400 | — | ↗ |
| 2024-02-28 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 15,000 | 0.12 | 1.8K | 82,400 | — | ↗ |
| 2024-02-27 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 10,000 | 0.13 | 1.3K | 67,400 | — | ↗ |
| 2024-02-26 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 13,200 | 0.12 | 1.6K | 57,400 | — | ↗ |
| 2024-02-01 | Zwicker Ian Harvey | Director | A-Award | A | Options | 100,000 | 0.15 | 15.0K | 100,000 | — | ↗ |
| 2024-02-01 | ZEN Wei Peu | Director | A-Award | A | Options | 100,000 | 0.15 | 15.0K | 100,000 | — | ↗ |
| 2024-02-01 | Stark Charles William | Officer | A-Award | A | Options | 200,000 | 0.15 | 30.0K | 200,000 | — | ↗ |
| 2024-02-01 | Sekulich George | Director / Officer | A-Award | A | Options | 200,000 | 0.15 | 30.0K | 200,000 | — | ↗ |
| 2024-02-01 | NAGASAKI YASUSHI | Officer | A-Award | A | Options | 200,000 | 0.15 | 30.0K | 200,000 | — | ↗ |
| 2024-02-01 | Lim Seah H. | Director | A-Award | A | Options | 100,000 | 0.15 | 15.0K | 100,000 | — | ↗ |
| 2024-02-01 | LEE WILLIS C | Director / Officer | A-Award | A | Options | 200,000 | 0.15 | 30.0K | 200,000 | — | ↗ |
| 2023-12-20 | Lim Seah H. | Director | S-Sale | D | Common stock, $0.001 par value | 32,500 | 0.05 | 1.6K | 4,586,626 | — | ↗ |
| 2023-12-15 | ZEN Wei Peu | Director | J-Other | A | Common stock, $0.001 par value | 3,760,983 | 0.29 | 1.09M | 4,768,817 | — | ↗ |
| 2023-12-15 | Lim Seah H. | Director | S-Sale | D | Common stock, $0.001 par value | 6,000 | 0.11 | 660.00 | 171,700 | — | ↗ |
| 2023-11-30 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 59,400 | 0.12 | 7.1K | 395,124 | — | ↗ |
| 2023-11-29 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 36,000 | 0.12 | 4.3K | 335,724 | — | ↗ |
| 2023-11-28 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 12,000 | 0.12 | 1.4K | 299,724 | — | ↗ |
| 2023-11-14 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,100 | 0.12 | 132.00 | 44,200 | — | ↗ |
| 2023-09-05 | Lim Seah H. | Director | P-Purchase | A | Common stock, $0.001 par value | 1,700 | 0.15 | 255.00 | 177,700 | — | ↗ |
| 2023-08-31 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 6,000 | 0.15 | 900.00 | 43,100 | — | ↗ |
| 2023-08-30 | Lim Seah H. | Director | P-Purchase | A | Common stock, $0.001 par value | 20,000 | 0.15 | 3.0K | 176,000 | — | ↗ |
| 2023-08-25 | Lim Seah H. | Director | P-Purchase | A | Common stock, $0.001 par value | 92,100 | 0.27 | 24.9K | 156,000 | — | ↗ |
| 2023-08-25 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 6,500 | 0.21 | 1.4K | 37,100 | — | ↗ |
| 2023-05-31 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 28,700 | 0.29 | 8.3K | 30,600 | — | ↗ |
| 2023-01-18 | ZEN Wei Peu | Director | J-Other | D | Convertible Promissory Note dated 2023-01-18 | 2,000,000 | 0.50 | 1.00M | 0 | — | ↗ |
| 2023-01-12 | Zwicker Ian Harvey | Director | A-Award | A | Options | 100,000 | 4.50 | 450.0K | 100,000 | — | ↗ |
| 2023-01-12 | ZEN Wei Peu | Director | A-Award | A | Options | 100,000 | 4.50 | 450.0K | 100,000 | — | ↗ |
| 2023-01-12 | Stark Charles William | Officer | A-Award | A | Options | 100,000 | 4.50 | 450.0K | 100,000 | — | ↗ |
| 2023-01-12 | Sekulich George | Officer | A-Award | A | Options | 100,000 | 4.50 | 450.0K | 100,000 | — | ↗ |
| 2023-01-12 | Niihara Yutaka | Officer | A-Award | A | Warrants (right to buy) | 7,500,000 | 4.50 | 33.75M | 0 | — | ↗ |
| 2023-01-12 | NAGASAKI YASUSHI | Officer | A-Award | A | Options | 150,000 | 4.50 | 675.0K | 150,000 | — | ↗ |
| 2023-01-12 | Lim Seah H. | Director | A-Award | A | Options | 100,000 | 4.50 | 450.0K | 100,000 | — | ↗ |
| 2023-01-12 | LEE WILLIS C | Officer | A-Award | A | Options | 750,000 | 4.50 | 3.38M | 750,000 | — | ↗ |
| 2022-11-30 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 22,900 | 0.41 | 9.4K | 12,040,857 | — | ↗ |
| 2022-11-29 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 14,700 | 0.38 | 5.6K | 12,017,957 | — | ↗ |
| 2022-11-28 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.35 | 1.8K | 12,003,257 | — | ↗ |
| 2022-11-04 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 7,500 | 0.45 | 3.4K | 11,998,257 | — | ↗ |
| 2022-11-03 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 2,500 | 0.45 | 1.1K | 11,990,757 | — | ↗ |
| 2022-11-02 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 15,000 | 0.43 | 6.5K | 11,988,257 | — | ↗ |
| 2022-11-01 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.43 | 2.2K | 11,973,257 | — | ↗ |
| 2022-10-31 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 7,500 | 0.45 | 3.4K | 11,968,257 | — | ↗ |
| 2022-10-28 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 7,500 | 0.42 | 3.2K | 11,960,757 | — | ↗ |
| 2022-10-27 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 22,500 | 0.27 | 6.1K | 11,953,257 | — | ↗ |
| 2022-10-26 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 11,900 | 0.27 | 3.2K | 11,930,757 | — | ↗ |
| 2022-10-25 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 20,000 | 0.26 | 5.2K | 11,918,857 | — | ↗ |
| 2022-10-24 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 7,500 | 0.22 | 1.7K | 11,898,857 | — | ↗ |
| 2022-10-21 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 10,000 | 0.19 | 1.9K | 11,891,357 | — | ↗ |
| 2022-10-20 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 30,000 | 0.18 | 5.4K | 11,881,357 | — | ↗ |
| 2022-10-19 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 25,000 | 0.16 | 4.0K | 11,851,357 | — | ↗ |
| 2022-10-18 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 30,000 | 0.19 | 5.7K | 11,826,357 | — | ↗ |
| 2022-10-17 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 15,000 | 0.20 | 3.0K | 11,796,357 | — | ↗ |
| 2022-10-14 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 35,000 | 0.17 | 6.0K | 11,781,357 | — | ↗ |
| 2022-10-13 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 62,500 | 0.18 | 11.3K | 11,746,357 | — | ↗ |
| 2022-10-12 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 160,000 | 0.08 | 12.8K | 11,683,857 | — | ↗ |
| 2022-10-11 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.09 | 450.00 | 11,523,857 | — | ↗ |
| 2022-10-10 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 10,000 | 0.09 | 900.00 | 11,388,857 | — | ↗ |
| 2022-10-09 | Lim Seah H. | Director | P-Purchase | A | Common stock, $0.001 par value | 25,400 | 0.11 | 2.8K | 63,900 | — | ↗ |
| 2022-10-07 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 4,000 | 0.13 | 520.00 | 11,378,857 | — | ↗ |
| 2022-10-06 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.15 | 750.00 | 11,374,857 | — | ↗ |
| 2022-10-05 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 10,000 | 0.15 | 1.5K | 11,369,857 | — | ↗ |
| 2022-10-04 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.16 | 800.00 | 11,359,857 | — | ↗ |
| 2022-10-04 | Lim Seah H. | Director | — | — | Common stock, $0.001 par value | 0 | 0.00 | — | 38,500 | D | ↗ |
| 2022-10-03 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 10,000 | 0.20 | 2.0K | 11,354,857 | — | ↗ |
| 2022-09-27 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.20 | 1.0K | 11,344,857 | — | ↗ |
| 2022-09-26 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 6,000 | 0.20 | 1.2K | 11,339,857 | — | ↗ |
| 2022-09-20 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 750 | 0.28 | 210.00 | 287,724 | — | ↗ |
| 2022-09-16 | Lim Seah H. | Director | — | D | Promissory Note due 9/16/2025 | 240,000 | 0.00 | — | 0 | — | ↗ |
| 2022-07-19 | LEE WILLIS C | Officer | P-Purchase | A | Common stock, $0.001 par value | 3,200 | 0.39 | 1.2K | 286,974 | — | ↗ |
| 2022-05-27 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 2,500 | 0.40 | 1.0K | 283,774 | — | ↗ |
| 2022-05-23 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 0.50 | 1.0K | 11,333,857 | — | ↗ |
| 2022-05-20 | Niihara Yutaka | Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 0.49 | 2.5K | 11,331,857 | — | ↗ |
| 2022-05-18 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 7,351 | 0.35 | 2.6K | 11,326,857 | — | ↗ |
| 2022-05-09 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,000 | 0.60 | 3.6K | 11,309,506 | — | ↗ |
| 2022-04-08 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,600 | 0.76 | 1.2K | 241,194 | — | ↗ |
| 2022-04-06 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,400 | 0.95 | 1.3K | 239,594 | — | ↗ |
| 2022-04-04 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 8,900 | 0.88 | 7.8K | 278,774 | — | ↗ |
| 2022-02-28 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 53,800 | 1.49 | 80.2K | 11,303,506 | — | ↗ |
| 2022-02-28 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 7,200 | 1.51 | 10.9K | 269,874 | — | ↗ |
| 2022-02-25 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 5,500 | 1.41 | 7.8K | 11,249,706 | — | ↗ |
| 2022-02-24 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 11,000 | 1.43 | 15.7K | 11,244,206 | — | ↗ |
| 2022-02-24 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 5,900 | 1.44 | 8.5K | 262,674 | — | ↗ |
| 2022-02-22 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 17,800 | 1.44 | 25.6K | 11,233,206 | — | ↗ |
| 2022-02-22 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.42 | 710.00 | 256,774 | — | ↗ |
| 2022-02-18 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.43 | 2.1K | 11,215,406 | — | ↗ |
| 2022-02-17 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,500 | 1.43 | 9.3K | 11,213,906 | — | ↗ |
| 2022-02-16 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.47 | 1.5K | 11,207,406 | — | ↗ |
| 2022-02-15 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,000 | 1.45 | 8.7K | 11,206,406 | — | ↗ |
| 2022-02-14 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,000 | 1.45 | 8.7K | 11,200,406 | — | ↗ |
| 2022-02-11 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 4,000 | 1.49 | 6.0K | 11,194,406 | — | ↗ |
| 2022-02-10 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,000 | 1.45 | 4.4K | 11,190,406 | — | ↗ |
| 2022-02-09 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 23,500 | 1.45 | 34.1K | 11,187,406 | — | ↗ |
| 2022-02-08 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,250 | 1.49 | 4.8K | 11,163,906 | — | ↗ |
| 2022-02-07 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 5,250 | 1.47 | 7.7K | 11,160,656 | — | ↗ |
| 2022-02-04 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 7,000 | 1.43 | 10.0K | 11,155,406 | — | ↗ |
| 2022-02-03 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,250 | 1.40 | 8.8K | 11,148,406 | — | ↗ |
| 2022-01-06 | Teranishi Lori | Director | — | I | Common stock, $0.001 par value | 0 | 0.00 | — | 18,161 | — | ↗ |
| 2022-01-03 | Lui Alfred Fu Kong | Director | P-Purchase | A | Common stock, $0.001 par value | 10,000 | 1.58 | 15.8K | 10,000 | — | ↗ |
| 2021-12-31 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 7,000 | 1.58 | 11.1K | 11,142,156 | — | ↗ |
| 2021-12-30 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,800 | 1.56 | 10.6K | 11,135,156 | — | ↗ |
| 2021-12-29 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,700 | 1.57 | 4.2K | 11,128,356 | — | ↗ |
| 2021-12-28 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.60 | 1.6K | 11,125,656 | — | ↗ |
| 2021-12-27 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,200 | 1.48 | 1.8K | 11,124,656 | — | ↗ |
| 2021-12-23 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.50 | 2.3K | 11,123,456 | — | ↗ |
| 2021-12-22 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 1.48 | 7.4K | 11,121,956 | — | ↗ |
| 2021-12-21 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 4,900 | 1.49 | 7.3K | 11,116,956 | — | ↗ |
| 2021-12-20 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,000 | 1.51 | 4.5K | 11,112,056 | — | ↗ |
| 2021-12-17 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,750 | 1.49 | 4.1K | 11,109,056 | — | ↗ |
| 2021-12-17 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.50 | 750.00 | 1,000 | — | ↗ |
| 2021-12-16 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 4,000 | 1.54 | 6.2K | 11,106,306 | — | ↗ |
| 2021-12-15 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,000 | 1.52 | 4.6K | 11,102,306 | — | ↗ |
| 2021-12-14 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.52 | 2.3K | 11,099,306 | — | ↗ |
| 2021-12-13 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.52 | 760.00 | 500 | — | ↗ |
| 2021-12-10 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.57 | 1.6K | 11,097,806 | — | ↗ |
| 2021-12-10 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 200 | 1.74 | 348.00 | 256,274 | — | ↗ |
| 2021-12-09 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.69 | 3.4K | 11,096,806 | — | ↗ |
| 2021-12-08 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,200 | 1.58 | 1.9K | 11,094,806 | — | ↗ |
| 2021-12-07 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,900 | 1.55 | 2.9K | 11,093,606 | — | ↗ |
| 2021-12-06 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.49 | 2.2K | 11,091,706 | — | ↗ |
| 2021-12-03 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.55 | 1.6K | 11,090,206 | — | ↗ |
| 2021-12-03 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.54 | 770.00 | 256,074 | — | ↗ |
| 2021-12-02 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,400 | 1.53 | 5.2K | 11,089,206 | — | ↗ |
| 2021-12-01 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 5,750 | 1.72 | 9.9K | 11,085,806 | — | ↗ |
| 2021-11-30 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 35,600 | 1.51 | 53.8K | 11,080,056 | — | ↗ |
| 2021-11-30 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 15,500 | 1.50 | 23.3K | 228,394 | — | ↗ |
| 2021-11-29 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 16,000 | 1.45 | 23.2K | 11,044,456 | — | ↗ |
| 2021-11-29 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 15,705 | 1.47 | 23.1K | 212,894 | — | ↗ |
| 2021-11-26 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 56,009 | 1.41 | 79.0K | 11,028,456 | — | ↗ |
| 2021-11-26 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 24,328 | 1.45 | 35.3K | 197,189 | — | ↗ |
| 2021-11-24 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 19,300 | 1.34 | 25.9K | 10,972,447 | — | ↗ |
| 2021-11-24 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 34,500 | 1.34 | 46.2K | 172,861 | — | ↗ |
| 2021-11-23 | Sekulich George | Officer | — | D | Common stock, $0.001 par value | 0 | 0.00 | — | 385 | — | ↗ |
| 2021-11-23 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 7,000 | 1.35 | 9.5K | 10,953,147 | — | ↗ |
| 2021-11-23 | Lui Alfred Fu Kong | Director | — | I | Common stock, $0.001 par value | 0 | 0.00 | — | 32,358 | — | ↗ |
| 2021-11-23 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 3,500 | 1.32 | 4.6K | 138,361 | — | ↗ |
| 2021-11-22 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 12,000 | 1.44 | 17.3K | 10,946,147 | — | ↗ |
| 2021-11-22 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 8,900 | 1.44 | 12.8K | 134,861 | — | ↗ |
| 2021-11-19 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 15,000 | 1.39 | 20.9K | 10,934,147 | — | ↗ |
| 2021-11-19 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 1.37 | 6.9K | 125,961 | — | ↗ |
| 2021-11-18 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 13,000 | 1.28 | 16.6K | 10,919,147 | — | ↗ |
| 2021-11-17 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 13,000 | 1.29 | 16.8K | 10,906,147 | — | ↗ |
| 2021-11-17 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.29 | 1.3K | 120,961 | — | ↗ |
| 2021-11-16 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 5,000 | 1.28 | 6.4K | 10,893,147 | — | ↗ |
| 2021-11-16 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 2,100 | 1.29 | 2.7K | 119,961 | — | ↗ |
| 2021-11-15 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.25 | 2.5K | 10,888,147 | — | ↗ |
| 2021-11-15 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,600 | 1.24 | 2.0K | 117,861 | — | ↗ |
| 2021-10-20 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.57 | 1.6K | 10,886,147 | — | ↗ |
| 2021-10-06 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.52 | 1.5K | 10,885,147 | — | ↗ |
| 2021-10-05 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.66 | 3.3K | 10,884,147 | — | ↗ |
| 2021-09-27 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.64 | 1.6K | 10,882,147 | — | ↗ |
| 2021-09-24 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.70 | 1.7K | 10,881,147 | — | ↗ |
| 2021-09-23 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.69 | 2.5K | 10,880,147 | — | ↗ |
| 2021-09-22 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,582 | 1.73 | 2.7K | 10,878,647 | — | ↗ |
| 2021-09-21 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.64 | 3.3K | 10,877,065 | — | ↗ |
| 2021-09-17 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.71 | 855.00 | 116,261 | — | ↗ |
| 2021-09-16 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.71 | 1.7K | 115,761 | — | ↗ |
| 2021-09-15 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.50 | 3.0K | 10,875,065 | — | ↗ |
| 2021-09-15 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.51 | 3.0K | 114,761 | — | ↗ |
| 2021-09-10 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.72 | 3.4K | 112,761 | — | ↗ |
| 2021-09-09 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,500 | 1.67 | 4.2K | 10,873,065 | — | ↗ |
| 2021-09-08 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.75 | 2.6K | 10,870,565 | — | ↗ |
| 2021-09-08 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.70 | 3.4K | 110,761 | — | ↗ |
| 2021-09-03 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.58 | 2.4K | 10,869,065 | — | ↗ |
| 2021-09-02 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.55 | 1.6K | 10,867,565 | — | ↗ |
| 2021-09-01 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.54 | 2.3K | 10,866,565 | — | ↗ |
| 2021-08-31 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 7,201 | 1.55 | 11.2K | 10,865,065 | — | ↗ |
| 2021-08-27 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.54 | 2.3K | 255,574 | — | ↗ |
| 2021-08-26 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 6,350 | 1.56 | 9.9K | 10,857,864 | — | ↗ |
| 2021-08-26 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.69 | 1.7K | 254,074 | — | ↗ |
| 2021-08-25 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 5,350 | 1.53 | 8.2K | 10,851,514 | — | ↗ |
| 2021-08-25 | LEE WILLIS C | Director / Officer | P-Purchase | A | Common stock, $0.001 par value | 2,400 | 1.51 | 3.6K | 253,074 | — | ↗ |
| 2021-08-24 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,500 | 1.48 | 2.2K | 10,846,164 | — | ↗ |
| 2021-08-23 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.45 | 2.9K | 10,844,664 | — | ↗ |
| 2021-08-20 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 4,600 | 1.44 | 6.6K | 10,842,664 | — | ↗ |
| 2021-08-19 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,600 | 1.47 | 3.8K | 10,838,064 | — | ↗ |
| 2021-08-18 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.50 | 1.5K | 10,835,464 | — | ↗ |
| 2021-08-17 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,200 | 1.49 | 4.8K | 10,834,464 | — | ↗ |
| 2021-08-16 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.55 | 775.00 | 10,831,264 | — | ↗ |
| 2021-08-13 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,793 | 1.54 | 5.8K | 10,830,764 | — | ↗ |
| 2021-08-12 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,000 | 1.50 | 3.0K | 10,826,971 | — | ↗ |
| 2021-08-11 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,800 | 1.53 | 2.8K | 10,824,971 | — | ↗ |
| 2021-08-09 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,200 | 1.50 | 1.8K | 10,823,171 | — | ↗ |
| 2021-08-06 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,900 | 1.53 | 6.0K | 10,821,971 | — | ↗ |
| 2021-08-05 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,600 | 1.50 | 2.4K | 10,818,071 | — | ↗ |
| 2021-08-04 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,800 | 1.48 | 4.1K | 10,816,471 | — | ↗ |
| 2021-08-03 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,200 | 1.47 | 4.7K | 10,813,671 | — | ↗ |
| 2021-08-02 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,600 | 1.47 | 3.8K | 10,810,471 | — | ↗ |
| 2021-07-30 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.50 | 750.00 | 10,807,871 | — | ↗ |
| 2021-07-29 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.50 | 1.5K | 10,807,371 | — | ↗ |
| 2021-07-28 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,400 | 1.46 | 3.5K | 10,806,371 | — | ↗ |
| 2021-07-27 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.50 | 750.00 | 10,803,971 | — | ↗ |
| 2021-07-26 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 500 | 1.50 | 750.00 | 10,803,471 | — | ↗ |
| 2021-07-23 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,100 | 1.49 | 1.6K | 10,802,971 | — | ↗ |
| 2021-07-22 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.49 | 1.5K | 10,801,871 | — | ↗ |
| 2021-07-21 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 3,100 | 1.46 | 4.5K | 10,800,871 | — | ↗ |
| 2021-07-20 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,800 | 1.47 | 2.6K | 10,797,771 | — | ↗ |
| 2021-07-19 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 2,100 | 1.46 | 3.1K | 10,795,971 | — | ↗ |
| 2021-07-16 | Niihara Yutaka | Director / Officer / 10% Owner | P-Purchase | A | Common stock, $0.001 par value | 1,000 | 1.50 | 1.5K | 10,793,871 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-10.3K
Shares Outstanding
70.19M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2020 | Yutaka Niihara, M.D., M.P.H. Chairman and Chief Executive Officer | 385.0K | — | — | — | — | — | 385.0K | 0.00% | ↗ |
| 2 | 2020 | Yasushi Nagasaki Chief Financial Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 3 | 2020 | Willis C. Lee Chief Operating Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 4 | 2019 | Yutaka Niihara, M.D., M.P.H. Chairman and Chief Executive Officer | 385.0K | — | — | — | — | — | 385.0K | 0.00% | ↗ |
| 5 | 2019 | Willis C. Lee Chief Operating Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 6 | 2019 | Yasushi Nagasaki Chief Financial Officer | 235.0K | — | — | — | — | — | 235.0K | 0.00% | ↗ |
| 7 | 2018 | George C. Carpenter IV (President and Chief Executive Officer) | 238.1K | 25.0K | 43.5K | 37.1K | — | — | 318.7K | 25.28% | ↗ |
| 8 | 2018 | Donald D'Ambrosio (Chief Financial Officer) | 215.0K | 20.0K | 29.7K | 13.6K | — | 16.8K | 295.2K | 14.67% | ↗ |
| 9 | 2017 | George C. Carpenter IV (President and Chief Executive Officer) | 270.0K | 25.0K | — | — | — | 21.0K | 316.0K | 0.00% | ↗ |
| 10 | 2017 | Paul Buck (Former Chief Financial Officer and Secretary) | 209.3K | — | — | — | — | — | 209.3K | 0.00% | ↗ |
| 11 | 2017 | Donald D'Ambrosio (Chief Financial Officer) | 117.3K | 20.0K | — | 104.6K | — | 8.3K | 180.5K | 57.95% | ↗ |
| 12 | 2017 | Donald D’Ambrosio (Chief Financial Officer) | 117.3K | 20.0K | — | 104.6K | — | 8.3K | 180.5K | 57.95% | ↗ |
| 13 | 2016 | George C. Carpenter IV (President and Chief Executive Officer) | 270.0K | — | 25.5K | 189.4K | — | 21.0K | 505.9K | 42.48% | ↗ |
| 14 | 2016 | Paul Buck (Chief Financial Officer and Secretary) | 208.0K | — | 25.5K | 189.4K | — | 8.5K | 431.4K | 49.81% | ↗ |
| 15 | 2016 | Paul Buck (Former Chief Financial Officer and Secretary) | 208.0K | — | 25.5K | 189.4K | — | 8.5K | 431.4K | 49.81% | ↗ |
| 16 | 2016 | Paul Buck (Chief Financial Officer and Secretary ( Retired) ) | 208.0K | — | 25.5K | 189.4K | — | 8.5K | 431.4K | 49.81% | ↗ |
| 17 | 2016 | Donald D’Ambrosio (Chief Financial Officer) | — | — | — | — | — | — | — | — | ↗ |
| 18 | 2015 | George C. Carpenter IV (President and Chief Executive Officer) | 270.0K | — | — | — | — | 19.5K | 289.5K | 0.00% | ↗ |
| 19 | 2015 | Paul Buck (Chief Financial Officer and Secretary) | 208.0K | — | — | — | — | 17.5K | 225.6K | 0.00% | ↗ |
| 20 | 2015 | Paul Buck (Chief Financial Officer and Secretary ( Retired) ) | 208.0K | — | — | — | — | 17.5K | 225.5K | 0.00% | ↗ |
| 21 | 2014 | George Carpenter (President and Chief Executive Officer) | 270.0K | — | — | 93.2K | — | 19.8K | 383.0K | 24.33% | ↗ |
| 22 | 2014 | Paul Buck (Chief Financial Officer) | 208.0K | — | — | 100.7K | — | 18.1K | 326.8K | 30.81% | ↗ |
| 23 | 2013 | George Carpenter (President and Chief Executive Officer) | 228.3K | — | — | 57.8K | — | 20.1K | 306.2K | 18.88% | ↗ |
| 24 | 2013 | George Carpenter (President and Chief Executive Officer ) | 228.3K | — | — | 57.8K | — | 20.1K | 306.2K | 18.88% | ↗ |
| 25 | 2013 | Paul Buck (Chief Financial Officer) | 167.6K | — | — | 66.1K | — | 20.7K | 254.4K | 25.98% | ↗ |
| 26 | 2013 | Daniel Hoffman (Chief Medical Officer through December 26, 2012) | 89.3K | — | — | — | — | — | 89.3K | 0.00% | ↗ |
| 27 | 2012 | Daniel Hoffman (Chief Medical Officer through December 26, 2012) | 187.0K | — | — | — | — | 20.7K | 207.7K | 0.00% | ↗ |
| 28 | 2012 | George Carpenter (President and Chief Executive Officer ) | 157.5K | — | — | — | — | 22.1K | 179.6K | 0.00% | ↗ |
| 29 | 2012 | Paul Buck (Chief Financial Officer) | 121.3K | — | — | — | — | 24.0K | 145.3K | 0.00% | ↗ |
| 30 | 2011 | George Carpenter (President and Chief Executive Officer ) | 304.1K | — | — | — | — | 21.8K | 325.9K | 0.00% | ↗ |
| 31 | 2011 | Daniel Hoffman (Chief Medical Officer through December 26, 2012) | 235.5K | — | — | — | — | 27.7K | 263.2K | 0.00% | ↗ |
| 32 | 2011 | Paul Buck (Chief Financial Officer) | 188.5K | — | — | — | — | 22.9K | 211.4K | 0.00% | ↗ |
| 33 | 2009 | George Carpenter (Chief Executive Officer, Principal Executive Officer, Director) | 180.0K | — | — | — | — | 20.5K | 200.5K | 0.00% | ↗ |
| 34 | 2009 | Leonard Brandt (Former Chief Executive Officer, Former Principal Executive Officer, Former Director) | 175.0K | — | — | — | — | 19.0K | 194.0K | 0.00% | ↗ |
| 35 | 2009 | Daniel Hoffman (President, Chief Medical Officer) | 108.1K | — | — | — | — | 39.2K | 147.3K | 0.00% | ↗ |
| 36 | 2008 | George Carpenter (Chief Executive Officer, Principal Executive Officer, Director) | 180.0K | — | — | 680.7K | — | 16.3K | 877.0K | 77.62% | ↗ |
| 37 | 2008 | George Carpenter (President) | 180.0K | — | — | 680.7K | — | 16.3K | 877.0K | 77.62% | ↗ |
| 38 | 2008 | Leonard Brandt (Chief Executive Officer, Principal Executive Officer, Director) | 175.0K | — | — | — | — | 19.0K | 194.0K | 0.00% | ↗ |
| 39 | 2008 | Brad Luce (former Principal Financial Officer) | 7.7K | — | — | 159.5K | — | — | 167.2K | 95.39% | ↗ |
| 40 | 2008 | Horace Hertz (former Chief Financial Officer, former Principal Financial Officer) | 157.9K | — | — | — | — | — | 157.9K | 0.00% | ↗ |
| 41 | 2008 | Daniel Hoffman (Chief Medical Officer) | 108.1K | — | — | — | — | 39.2K | 147.3K | 0.00% | ↗ |
| 42 | 2008 | Daniel Hoffman (President, Chief Medical Officer) | — | — | — | — | — | — | — | — | ↗ |
| 43 | 2008 | Leonard Brandt (Former Chief Executive Officer, Former Principal Executive Officer, Former Director) | — | — | — | — | — | — | — | — | ↗ |
| 44 | 2007 | Leonard Brandt (Chief Executive Officer, Principal Executive Officer, Director) | 175.0K | — | — | — | — | 18.0K | 1.22M | 0.00% | ↗ |
| 45 | 2007 | Horace Hertz (former Chief Financial Officer, former Principal Financial Officer) | 143.8K | — | — | 515.4K | — | — | 659.2K | 78.19% | ↗ |
| 46 | 2006 | Leonard Brandt (Chief Executive Officer, Principal Executive Officer, Director) | 175.0K | 10.0K | — | — | — | 59.7K | 441.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kurt H. Kruger | Consultant | 300.0K | male |
| Willis C. Lee | Chief Executive Officer & Chairman of the Board | 248.2K | male |
| Charles W. Stark | Chief Science Officer and EVP of Clinical Development & Medical Affairs | 218.8K | — |
| Hiroko Huynh | Chief Accounting Officer | 100.0K | female |
| Dale E. Short | Legal Consultant & Corporate Secretary | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMMA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
